Flexion Therapeutics Revenue and Competitors

Boston, MA USA

Location

$92M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Flexion Therapeutics's estimated annual revenue is currently $4M per year.(i)
  • Flexion Therapeutics received $Undisclosed in venture funding in October 2017.
  • Flexion Therapeutics's estimated revenue per employee is $77,500
  • Flexion Therapeutics's total funding is $92M.

Employee Data

  • Flexion Therapeutics has 51 Employees.(i)
  • Flexion Therapeutics grew their employee count by -19% last year.

Flexion Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder/CEOReveal Email/Phone
2
SVP CMC OperationsReveal Email/Phone
3
General Counsel & Corporate SecretaryReveal Email/Phone
4
Chief Strategy OfficerReveal Email/Phone
5
Director, Contracting & PricingReveal Email/Phone
6
Director Quality OperationsReveal Email/Phone
7
Associate Director, Events & Field OperationsReveal Email/Phone
8
Chief Strategy OfficerReveal Email/Phone
9
Director Strategic Accounts - NortheastReveal Email/Phone
10
Muscular Business Manager with Flexion TherapeuticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Flexion Therapeutics?

Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts. View our terms of use: https://flexiontherapeutics.com/terms-of-use/

keywords:N/A

$92M

Total Funding

51

Number of Employees

$4M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Flexion Therapeutics News

2022-04-20 - Global Osteoarthritis Therapeutics Market Research Report ...

Horizon Therapeutics, Sanofi, Pfizer, Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Abbott, Anika Therapeutics, Eli Lilly, Flexion Therapeutics.

2022-04-17 - Mass. biotechs have cut jobs in 2022 - Boston Business Journal

Flexion Therapeutics: Florida-based Pacira BioSciences Inc. · Deciphera Pharmaceuticals: Deciphera Pharmaceuticals Inc. · Kaleido Biosciences:...

2022-03-30 - Movers & Shakers, April 1 | BioSpace

He most recently served as the CFO of Flexion Therapeutics. Prior to Flexion, Driscoll was the CFO of Novavax, Inc. He previously served as...

2012-12-04 - Flexion Therapeutics Raises $20M in Series B Financing

Flexion Therapeutics, a Woburn, MA-based company that discovers and develops innovative therapeutics for musculoskeletal disorders, has raised $20m in Series B financing. The round led by new investor Novo Ventures, with participation from existing investors 5AM Ventures, Pfizer Venture Investm ...

2010-01-29 - Flexion Therapeutics Closes $42M Series A Funding and Three in-licensing Deals

Flexion Therapeutics, aWoburn, MA-based developer of drug candidates through clinically meaningful proof of concept and beyond, has received an equity financing from Pfizer Venture Investments which allowed the company to close its $42m Series A financing round. The investment follow the comple ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M516%N/A
#2
$15.1M514%N/A
#3
$15.1M516%N/A
#4
$4.6M519%N/A
#5
$14.7M5142%N/A

Flexion Therapeutics Funding

DateAmountRoundLead InvestorsReference
2009-10-19$33.0MAVersant VenturesArticle
2010-02-01$9.0MUndisclosedPfizer Venture InvestmentsArticle
2012-12-05$20.0MBNovo VenturesArticle
2014-12-15$98.5MUndisclosedBMO Capital Markets Corp.Article
2015-08-05$30.0MUndisclosedMidCap FinancialArticle
2017-04-28$175.0MUndisclosedArticle
2017-10-12$UndisclosedUndisclosedWells Fargo SecuritiesArticle